The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AMERISOURCEBERGEN CORP | COM | 03073E105 | 17,125 | 212,000 | SH | SOLE | 212,000 | 0 | 0 | ||
| ANIKA THERAPEUTICS INC | COM | 035255108 | 9,737 | 203,493 | SH | SOLE | 203,493 | 0 | 0 | ||
| ANTHEM INC | COM | 036752103 | 17,030 | 135,900 | SH | SOLE | 135,900 | 0 | 0 | ||
| CARDINAL HEALTH INC | COM | 14149Y108 | 17,933 | 230,800 | SH | SOLE | 230,800 | 0 | 0 | ||
| CHARLES RIV LABS INTL INC | COM | 159864107 | 9,885 | 118,612 | SH | SOLE | 118,612 | 0 | 0 | ||
| GNC HLDGS INC | COM CL A | 36191G107 | 9,862 | 482,955 | SH | SOLE | 482,955 | 0 | 0 | ||
| IMMUCELL CORP | COM PAR $0.10 | 452525306 | 1,301 | 168,323 | SH | SOLE | 168,323 | 0 | 0 | ||
| INC RESH HLDGS INC | CL A | 45329R109 | 9,936 | 222,875 | SH | SOLE | 222,875 | 0 | 0 | ||
| ISHARES TR | 1-3 YR TR BD ETF | 464287457 | 850 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
| MERCK & CO INC | COM | 58933Y105 | 9,805 | 157,100 | SH | SOLE | 157,100 | 0 | 0 | ||
| PROGENICS PHARMACEUTICALS IN | COM | 743187106 | 1,772 | 280,000 | SH | SOLE | 280,000 | 0 | 0 | ||
| SPDR SERIES TRUST | BRCLYS 1-3MT ETF | 78464A680 | 915 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
| SUPERNUS PHARMACEUTICALS INC | COM | 868459108 | 9,386 | 379,533 | SH | SOLE | 379,533 | 0 | 0 | ||
| TARO PHARMACEUTICAL INDS LTD | SHS | M8737E108 | 9,416 | 85,205 | SH | SOLE | 85,205 | 0 | 0 | ||
| TRIPLE-S MGMT CORP | CL B | 896749108 | 9,428 | 429,904 | SH | SOLE | 429,904 | 0 | 0 | ||